COMPANY SPOTLIGHT - Genzyme.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      The article provides updates regarding the developments in the pharmaceutical industry Genzyme Corp. in the U.S. Accordingly, the company, along with Isis Pharmaceuticals have released positive results from their Phase III study of mipomersen in patients with homozygous familial hypercholesterolemia or hoFH. It further notes that the study has net its primary endpoint in an intent-to-treat analysis. Information regarding the SWOT analysis of the company is discussed.